Lipid metabolism modulation via medium-chain triglycerides

"Lipid metabolism modulation via medium-chain triglycerides" is not a specific molecular target, but rather describes the physiological effects of medium-chain triglycerides (MCTs) on human lipid metabolism. MCTs are dietary fats composed of fatty acids with chain lengths of six to twelve carbons—primarily caproic acid (C6), caprylic acid (C8), capric acid (C10), and lauric acid (C12)[6]. Unlike long-chain triglycerides, MCTs are rapidly absorbed from the gut directly into the portal circulation without requiring bile salts or pancreatic enzymes. They are quickly transported to the liver where they undergo β‑oxidation to produce acetyl-CoA—a substrate for energy generation—or converted into ketone bodies during carbohydrate restriction. MCT supplementation has been shown to increase thermogenesis and fat oxidation rates while suppressing appetite through increased GLP‑1 secretion. These properties make them useful in clinical nutrition for patients with fat malabsorption disorders as well as potential adjunctive therapy in weight management programs. Additionally, there is evidence that MCT consumption may improve cognitive function in certain populations by providing an alternative brain fuel source via ketones. However, "lipid metabolism modulation via medium-chain triglycerides" does not refer to a discrete protein/receptor/enzyme but rather encompasses multiple metabolic pathways influenced by dietary intake of these fats. Therefore it should not be classified as a canonical drug target such as an enzyme or receptor.[1][2][3]

Other names

Medium-chain triglyceride metabolismMCT-induced lipid modulationMCTs and lipid metabolism

Rapid absorption and direct transport to the liver via portal vein without need for bile salts or carnitine. Undergo β‑oxidation to acetyl-CoA for energy production. Promote ketone body formation under low-carbohydrate conditions. Upregulate genes involved in mitochondrial biogenesis and fat oxidation through Akt/AMPK signaling pathways. Suppress appetite by increasing GLP‑1 secretion and delaying gastric emptying.